|
Ovary, Fallopian Tube
|   |
|
Ovary, Fallopian Tube
| |
Primary Ovary or Fallopian Tube Neoplasia (SOVRR)
- For resection specimens with primary malignant tumors of ovary, fallopian tube, or peritoneum, including all primary epithelial borderline tumors and carcinomas, carcinosarcoma, malignant germ cell tumors, and malignant sex cord-stromal tumors. Not for use with peritoneal mesothelioma. If bilateral tumors of two different histologic types are present, separate case summaries should be used for each tumor.
Specimen and Surgical Procedure
Specimen, procedure...................................................................
Specimen integrity*
Right ovary...................................capsule intact/capsule ruptured/fragmented
Left ovary.....................................capsule intact/capsule ruptured/fragmented
Right fallopian tube........................serosa intact/serosa ruptured/fragmented
Left fallopian tube.........................serosa intact/serosa ruptured/fragmented
Lymph nodes submitted and/or identified in the specimen................... yes/no
Tumor
Primary tumor site …………..R/L/bilateral ovaries/tubes/tubo-ovarian or primary peritoneum
Ovarian surface involvement..................... present(specify laterality)/absent/indeterminate
Fallopian tube surface involvement............ present(specify laterality)/absent/indeterminate
Tumor size..... (report for each primary tumor, specifying by laterality) ___ cm
Histologic type..............................................................................
Histologic grade**.........................................................................
Implants***.......................................not sampled/not identified/present (specify site(s):)
Other tissue/organ involvement.......................................................
Largest extrapelvic peritoneal focus
Size.....................................microscopic/macroscopic(≤2 cm)/macroscopic(>2 cm)
Specify site.........................................................................
Peritoneal/ascitic fluid...................................................not submitted/negative/atypical or suspicious(explain:)/positive/nondiagnostic(explain:)
Treatment effect............................................................................
Lymph Nodes**** (required only if lymph nodes are present in the specimen)
Total number of nodes examined: _____
Specify site(s)#: ____________________________
Location of largest deposit (include laterality): ____________________________
Number of nodes with metastasis greater than 10 mm: _____
Number of nodes with metastasis 10 mm or less (excludes ITCs): _____
Number of nodes with isolated tumor cells (ITCs) (0.2 mm or less): _____
Size of largest metastatic deposit (millimeters): _____ mm
# Note: Information should include location and laterality of lymph nodes examined.
Pathologic stage (AJCC 8th ed.)........................................................... pT__N__M__
*Note: For primary ovarian tumors, if the ovary containing primary tumor is removed intact into a laparoscopy bag and ruptured in the bag by the surgeon without spillage into the peritoneal cavity (to allow for removal via laparoscopy port site or small incision), the specimen integrity should be listed as “capsule intact” with a comment explaining this in the report.